{
  "ticker": "EW",
  "company": "Edwards Lifesciences",
  "quarter": "Q3 2025",
  "date": "2025-07-28",
  "content": "Edwards Lifesciences Financial Overview\nData as of: 2025-07-28\n\nCompany Metrics:\nStock Price: $0.33\nMarket Cap: $1,175,749,158\n52-Week High: $0.43\n52-Week Low: $0.23\n\nValuation Metrics:\nP/E Ratio (TTM): 45.4\nForward P/E: 40.8\nPEG Ratio: 2.57\nPrice to Book: 5.4\n\nFinancial Performance:\nRevenue (TTM): $221,015,841\nRevenue Growth (YoY): 31.8%\nGross Margin: 28.3%\nOperating Margin: 5.6%\nNet Margin: 3.5%\n\nProfitability:\nReturn on Assets: 19.9%\nReturn on Equity: 21.3%\nProfit Margin: 3.5%\n\nTrading Information:\nBeta: 1.49\nDividend Yield: 3.76%\nPrevious Close: $0.32\nDay Range: $0.32 - $0.34\nVolume: 11,684,053\nAverage Volume: 13,466,930",
  "source": "batch-cache",
  "cached_at": "2025-07-28T21:15:02.804873"
}